Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of dydrogesterone vs medroxyprogesterone acetate for PPOS in poor ovarian responders
ChiCTR2100049623Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in poor ovarian response (POR) comparing PPOS with dydrogesterone with PPOS with medroxyprogesterone acetate (2 arms). Primary endpoint: number_of_oocytes_retrieved. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
dydrogesteronemedroxyprogesterone acetate
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on ChiCTR2100049623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049623.